Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000902664-20-002022
Filing Date
2020-05-08
Accepted
2020-05-08 16:30:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 CHINA BIOLOGIC PRODUCTS HOLDINGS, INC. p20-0978sc13da.htm SC 13D/A 55521
  Complete submission text file 0000902664-20-002022.txt   57534
Mailing Address 18TH FL, JIALONG INTERNATIONALBUILDING 19 CHAOYANG PARK ROAD, CHAOYANG DISTRICT BEIJING F4 100125
Business Address 18TH FL, JIALONG INTERNATIONALBUILDING 19 CHAOYANG PARK ROAD, CHAOYANG DISTRICT BEIJING F4 100125 86-10-6598-3111
China Biologic Products Holdings, Inc. (Subject) CIK: 0001369868 (see all company filings)

EIN.: 752308816 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-83122 | Film No.: 20861022
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O DMS HOUSE, 20 GENESIS CLOSE PO BOX 2587 GEORGE TOWN, GRAND CAYMAN E9 KY1-1103
Business Address C/O DMS HOUSE, 20 GENESIS CLOSE PO BOX 2587 GEORGE TOWN, GRAND CAYMAN E9 KY1-1103 (345) 749-8643
HILLHOUSE CAPITAL ADVISORS, LTD. (Filed by) CIK: 0001762304 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A